EN
- Lactobacillus rhamnosus CCFM1119,
- Lactobacillus crispatus CCFM1118,
- Lactobacillus helveticus CCFM1121,
- Lactobacillus plantarum CN2018,
- Bifidobacterium longum CCFM760
- 1) Inhibits Helicobacter pylori growth and colonization
- 2) Reduces adhesion of H. pylori to gastric mucosa
- 3) Supports gastric mucosal barrier protection
- 4) Helps reduce gastric inflammation and discomfort
- 5) Modulates immune response in the stomach
- 6) Supports long-term gastric health
HelpGut® Gut Health - Inhibite Helicobacter Pylori
Formulation
Functionality
Scientific Support
Human clinical trial
1) Evaluation of the Potential Protective Effects of Lactobacillus Strains against Helicobacter pylori Infection: A Randomized, Double-Blinded, Placebo-Controlled Trial.
2) Clinical efficacy evaluation of Lactobacillus rhamnosus JS-SZ-2-1 against Helicobacter pylori infection.
Pre-clinical paper
1) Jiangnan University, Bifidobacterium longum CCFM760 combined with lactulose alleviates loperamide-induced constipation by regulating the gut microbiota and improving short-chain fatty acid metabolism.
Patent
1) Jiangnan University, A medicinal product for the prevention and/or treatment of alcoholic bowel damage. Granted Publication Number CN111603490B
2) Jiangnan University, Lactobacillus plantarum for resisting helicobacter pylori infection and application thereof. Granted Publication Number: CN102174450B
3) Jiangnan University, Lactobacillus rhamnosus and application thereof in inhibiting helicobacter pylori. Granted Publication Number: CN111607538B
4) Jiangnan University, A strain of Lactobacillus crispatus capable of preventing and/or treating Helicobacter pylori infection. Granted Publication Number: CN111548970B
5) Jiangnan University, A strain of Bifidobacterium longum and its application. Granted Publication Number: CN107893044B